Third Party Inspections Await Reconciliation of Technical Corrections Bills
This article was originally published in The Gray Sheet
Executive Summary
Third-party inspection proponents are hoping that momentum from House passage of the Medical Device User Fee & Modernization Act technical corrections bill will propel enactment within the next few weeks
You may also be interested in...
Regulatory News In Brief
CDRH's Kessler on public radio: "Stents are fantastic inventions by medical device companies. I just don't think that the public has any clue that this industry is out there. People talk - with all respect to my sister agency - drugs, drugs, drugs and those are wonderful, but there is technology out there that is really working and the medical device field is outstanding," Office of Science & Engineering Laboratories Director Larry Kessler remarked during an Oct. 6 Kojo Nnamdi Show highlighting the CDRH science office. Later, Kessler alluded to fake Prolene surgical mesh manufactured by a company in India. OSEL testing found that although the counterfeiter's attempt at the J&J product did have some sterility problems, it largely worked as intended. Kessler also discussed timing for OSEL research: "We try to start studies that we do that are going to reflect products that come into the agency for approval anywhere from one to as much as five years ahead of time." Kessler added: "We have been doing a lot of work, for example, in laser diagnosis - that is, using light to diagnose conditions. We are trying to really move ahead, and some of these studies take six months to a year, sometimes two" years...
Regulatory News In Brief
CDRH's Kessler on public radio: "Stents are fantastic inventions by medical device companies. I just don't think that the public has any clue that this industry is out there. People talk - with all respect to my sister agency - drugs, drugs, drugs and those are wonderful, but there is technology out there that is really working and the medical device field is outstanding," Office of Science & Engineering Laboratories Director Larry Kessler remarked during an Oct. 6 Kojo Nnamdi Show highlighting the CDRH science office. Later, Kessler alluded to fake Prolene surgical mesh manufactured by a company in India. OSEL testing found that although the counterfeiter's attempt at the J&J product did have some sterility problems, it largely worked as intended. Kessler also discussed timing for OSEL research: "We try to start studies that we do that are going to reflect products that come into the agency for approval anywhere from one to as much as five years ahead of time." Kessler added: "We have been doing a lot of work, for example, in laser diagnosis - that is, using light to diagnose conditions. We are trying to really move ahead, and some of these studies take six months to a year, sometimes two" years...
Third-Party Inspection Training Stymied By Lack Of Industry Hosts
Implementation of FDA's accredited persons (AP) inspection program may require the agency to conduct compliance audits in addition to those scheduled in the Office of Regulatory Affairs workplan